Silver: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies is a biopharmaceutical company founded on Dr. Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body.

We leverage this intracellular approach to deliver treatments that will be transformative for people living with complex psychiatric and neurologic diseases. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do create and deliver.

Our mission is to develop innovative treatments to improve the lives of individuals with neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers.

Company Details